Bixiye
P63-21 Member Protections from Conversion Therapy
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2021
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2071 - 2080 ee natiijooyinka 3167
Bixiye
P64-21 Update to Reimbursement Policy Durable Medical Equipment (DME) - 002 Oxygen Aiding Equipment
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2021
Bixiye
P65-21 Change in Claim Submission for Medicare Members for COVID-19 Vaccines and Monoclonal Antibody Treatment
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2021
Bixiye
P61-21 Evaluation and Management Reimbursement Changes
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2021
Bixiye
2021 November Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2021
Bixiye
QP80-21 BlueRideSM announces No-Load Pilot Program for Non-Emergency Medical Transportation (NEMT) in Greater Minnesota
Taariikhda uu dhaqangalayo barnaamijka: Okt 27, 2021
Bixiye
QP81-21 Save the Date: Best Practices in Value-Based Arrangements
Taariikhda uu dhaqangalayo barnaamijka: Okt 27, 2021
Bixiye
QP82-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Accrufer™ (ferric maltol)
Taariikhda uu dhaqangalayo barnaamijka: Okt 27, 2021
Bixiye
QP83-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Kerendia®
Taariikhda uu dhaqangalayo barnaamijka: Okt 27, 2021
Bixiye
QP84-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Cholestasis Pruritis
Taariikhda uu dhaqangalayo barnaamijka: Okt 27, 2021